Zobrazeno 1 - 10
of 34
pro vyhledávání: '"S. M. Rudich"'
Autor:
Alan B. Leichtman, Herwig Ulf Meier-Kriesche, Bruce Kaplan, J. D. Punch, S. M. Rudich, J.A Arndorfer, A.O Ojo, Friedrich K. Port
Publikováno v:
Transplantation Proceedings. 33:1204-1206
Autor:
Prabir Roy-Chaudhury, Abhijit Sinha Roy, S M. Rudich, Jianhua Zhang, Yang Wang, Mahesh Krishnamoorthy, Saeb F. Khoury, Rupak K. Banerjee, Lois J. Arend
Publikováno v:
Kidney international. 74(11)
Venous stenosis is a significant problem in arteriovenous fistulae, likely due to anatomical configuration and wall shear stress profiles. To identify linkages between wall shear stress and the magnitude and pattern of vascular stenosis, we produced
Autor:
Joseph F. Buell, J.E Martin, Leslie Trumball, Maryetta Bass, E. Steve Woodle, Dave Wetzel, S M. Rudich, Ed Zavala, M.J. Thomas, Frederick L. Weber, Joseph S. Solomkin, Michelle Gearhart, Michael J. Hanaway, Jaime Aranda-Michel
Publikováno v:
ResearcherID
Background: Liver transplant recipients are at high risk for multi-drug resistant infections because of broad-spectrum antibiotic and immunosuppression. This study evaluates the clinical and financial impact of vancomycin resistant Enterococcus (VRE)
Autor:
Snezana Petrovic, Zhaohui Wang, Kathy Tenrani, Manoocher Soleimani, Robert A. Casero, Sharon Barone, Kamyar Zahedi, Alex B. Lentsch, Tomohisa Okaya, S M. Rudich
Publikováno v:
American journal of physiology. Cell physiology. 289(4)
Ischemia-reperfusion injury (IRI) in liver and other organs is manifested as an injury phase followed by recovery and resolution. Control of cell growth and proliferation is essential for recovery from the injury. We examined the expression of three
Autor:
S M. Rudich, M. Gearhart, Joseph F. Buell, M.J. Thomas, E. S. Woodle, C R. Schneider, Michael J. Hanaway
Publikováno v:
Transplantation proceedings. 37(2)
The purpose of this study was to evaluate the clinical impact of methicillin-resistant Staphylococcus aureus (MRSA) infections on transplant recipients. Methods. Liver and kidney recipients with MRSA infections were retrospectively identified and com
Autor:
Robert M. Merion, S. M. Rudich, Juan D. Arenas, Martin A. Maraschio, J. D. Punch, John C. Magee, Darrell A. Campbell, Liise K. Kayler
Publikováno v:
Transplantation proceedings. 35(4)
Background Venous thrombosis remains an important cause of pancreatic graft loss. Nevertheless, reports are scarce of treatment alternatives to complete graft removal. We describe a case of surgical salvage of a partial pancreatic graft thrombosis. M
Outcomes of pediatric living donor renal transplant after laparoscopic versus open donor nephrectomy
Autor:
Darrell A. Campbell, S. M. Rudich, Martin A. Maraschio, Liise K. Kayler, Robert M. Merion, J. D. Punch, S. E. Thomas, John C. Magee, Juan D. Arenas
Publikováno v:
Transplantation proceedings. 34(8)
Autor:
Leslie Ain McClure, Robert J. Fontana, Juan D. Arenas, Hero K. Hussain, Hahn V. Nghiem, S. M. Rudich, Jorge A. Marrero, Joel K. Greenson, Halimi Hamidullah
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 8(12)
The incidence of hepatocellular carcinoma (HCC) is increasing in the United States. Although liver transplantation is an effective means of treating selected patients, pretransplantation tumor progression may preclude some patients from undergoing tr
Autor:
R V, Perez, D J, Brown, S A, Katznelson, J A, Dubin, H G, Müller, T, Chang, S M, Rudich, J P, McVicar, G A, Kaysen
Publikováno v:
Transplantation. 69(5)
There are presently no established pre-transplant tests that consistently identify patients who may be at increased risk for acute rejection episodes after renal transplantation. We studied whether pretransplant serum levels of C-reactive protein (CR
Autor:
J C, Magee, R S, Sung, J G, Turcotte, J D, Punch, A O, Ojo, D M, Cibrik, J W, Konnak, D A, Bloom, J S, Wolf, B, Kaplan, S M, Rudich, T E, Bunchman, A B, Leichtman, R M, Merion, D A, Campbell
Publikováno v:
Clinical transplants.
The Michigan Kidney Transplant Program has existed for 35 years. Outcomes have improved dramatically as the one-year survival of cadaver kidney grafts increased from 25% to 85-90%. Patient deaths in the first year are now uncommon. Indications for re